2 The procedure

2.1 Indications and current treatments

2.1.1 Osteoarthritis of the knee is the result of progressive degeneration of the menisci and articular cartilage of the joint, leading to exposure of the bone surface. It causes pain, stiffness, swelling and difficulty in walking.

2.1.2 Treatment options depend on the severity of the osteoarthritis. Conservative treatments include medication to relieve pain and inflammation, physiotherapy and/or prescribed exercise and corticosteroid injection. Surgical options include upper tibial osteotomy to realign the leg and unicompartmental knee replacement. Patients with severe osteoarthritis may need total knee replacement.

2.2 Outline of the procedure

2.2.1 The aim of this procedure is to relieve pain, increase function and prevent damaging eccentric loading of the knee, thereby delaying progression of osteoarthritis and the need for total knee replacement. This procedure aims to correct the leg axis so that the line that passes through the centre of the hip to the centre of the ankle joint also passes through the centre of the knee joint (as in people without eccentric knee loading). This is achieved by insertion of an individually MRI-designed metallic implant into either the medial or lateral compartment of the knee joint (whichever is required).

2.2.2 An MRI scan of the knee is performed to enable bespoke design of a metallic implant. The operation is usually carried out with the patient under general anaesthesia, and may be done as day surgery. Before implantation, the patient may have an arthroscopic procedure to remove osteophytes. The individually designed metallic implant is inserted into either the medial or lateral compartment of the knee joint, depending on the change in leg axis required. Fluoroscopy may be used to confirm the position of the implant.

Sections 2.3 and 2.4 describe efficacy and safety outcomes from the published literature that the Committee considered as part of the evidence about this procedure. For more detailed information on the evidence, see the overview.

2.3 Efficacy

2.3.1 In a case series of 27 patients with early- to mid-stage unicompartmental osteoarthritis of the knee treated by arthroscopic removal of osteophytes followed by insertion of an MRI-designed implant, the average correction in leg axis was –4.4° preoperatively to –0.9° postoperatively. Successful leg axis correction to 0° and/or slight undercorrection of up to 2° was reported in 85% (23/27) of patients (preoperative leg axis measurements not given). The remaining 4 patients were reported to have had overcorrections of leg axis of 0.2°, 0.5° and 0.9° (2 patients). The follow-up MRI showed a low average loss of correction of 0.5° (range 0–1°) at 12–22 months. For all 27 patients, the correlation coefficient between implant offset (minimal thickness of the implant) and extent of axis correction was reported to be 0.84 (a value of 0.80 was considered 'good').

2.3.2 The Specialist Advisers listed key efficacy outcomes as reduced pain, ability to return to work and ability to perform activities of daily living and sports. They considered uncertainties about the efficacy of the procedure to be similar to the uncertainties relating to the non-customised implants that preceded the MRI-designed implant. These include failure to provide good pain relief, dislocation or subluxation of the device and a high revision rate compared with standard types of knee replacement.

2.4 Safety

2.4.1 The case series reported that there were no dislocations during or after the procedure but did not report any other safety data. Implant dislocation was reported in 7% (4/60) of patients after insertion of an MRI-designed implant in an unpublished case series.

2.4.2 A revision rate of approximately 5% after insertion of an MRI-designed implant was reported in an unpublished trial of 84 patients (absolute number and time of occurrence not stated).

2.4.3 The Specialist Advisers considered theoretical adverse events to include implant dislocation, infection, persistence of pain and venous thromboembolism. One Specialist Adviser expressed concern that loosening of the implant may cause further wear to the joint, which may make knee replacement more difficult.

  • National Institute for Health and Care Excellence (NICE)